PRRT2 and neoplasm: Its tumor-promoting activity seems to be associated to the nature and extent of the reversibility of PKC activation (Newton, 2018b), which in parallel is associated to the affinity of this molecules for the C1B domain and the effect of these molecules on the translocation of PKC to the plasma membrane.